




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Interventions and Imaging</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=f332074b-7154-4115-a60f-48ec06836c44</link>
        <description>Clinical Topic Feed: Interventions and Imaging</description>
        <language>en</language>

        

                <item>
                    <title>Eagle&#226;€™s Eye View: Imaging Identifies HCM Patients at High-Risk of Adverse Outcomes </title>
<link>/Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment.</description>
                    <pubdate>1779288780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ORBITA Analysis: Microvascular Resistance Impacts PCI Benefit</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/04/11/24/ORBITA-Analysis</link>                    <description>Patients with lower microvascular resistance (MVR) saw greater placebo-controlled benefit from PCI, according to a retrospective analysis of the ORBITA trial published April 29 in JACC: Cardiovascular Interventions.</description>
                    <pubdate>1778087340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC.26 Coronary Interventional Trials</title>
<link>/Latest-in-Cardiology/Articles/2026/04/27/19/07/ACC26-Coronary-Interventional-Trials</link>                    <description>Late-breaking clinical trials presented at ACC.26 focusing on coronary interventions included several looking at intravascular guidance in complex, high-risk procedures (IVUS-CHIP), bifurcation lesions (DKCRUSH VIII), and unprotected left main PCI (OPTIMAL).</description>
                    <pubdate>1777570260000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>IVUS-CHIP and OPTIMAL: IVUS-Guided vs. Angiography-Guided PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-1045am-combo-acc-2026</link>                    <description>When compared with angiography-guided PCI, IVUS-guided PCI was found to be not superior in patients with complex coronary arteries according to results from the IVUS-CHIP trial or in patients with unprotected left main coronary artery disease (LM-CAD) according to results from the OPTIMAL trial. Both trials were presented in a Late-Breaking Clinical Trial session at ACC.26 in New Orleans.</description>
                    <pubdate>1774885860000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>DKCRUSH VIII: IVUS-Guided PCI Superior to Angiography-Guided PCI in Complex Coronary Lesions</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-1045am-dkcrush-acc-2026</link>                    <description>When using the two-stent double-kissing (DK) crush technique for PCI to treat complex coronary artery bifurcation lesions, IVUS-guided PCI was associated with a greater reduction in target vessel failure compared to angiography-guided PCI, according to the DKCRUSH VIII trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in JACC.</description>
                    <pubdate>1774885560000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ALL-RISE: AI-Supported Coronary Flow Assessment Performs Similarly to Gold-Standard Wire-Based Testing</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-allrise-acc-2026</link>                    <description>FFRangio, a minimally invasive, artificial intelligence (AI)-assisted, novel method of measuring fractional flow reserve (FFR), performed similarly to traditional wire-based testing in patients with coronary artery disease (CAD) undergoing assessment for PCI, according to results from the ALL-RISE trial presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in NEJM.</description>
                    <pubdate>1774791240000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CHIP-BCIS3: LV Unloading Not Beneficial During PCI in Patients With Severe LV Dysfunction</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-chip-bcis3-acc-2026</link>                    <description>Among patients with severe left ventricular (LV) dysfunction and severe coronary heart disease undergoing complex PCI, elective LV unloading with a microaxial flow pump did not reduce the risk of major adverse clinical outcomes and carried a greater risk of all-cause and cardiovascular mortality...</description>
                    <pubdate>1774791180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>FAST III: Novel Minimally Invasive vFFR Noninferior to FFR For Revascularization</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-fastIII-acc-2026</link>                    <description>Vessel fractional flow reserve (vFFR)-guided revascularization was noninferior to pressure-wire-based fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary lesions, according to results from the FAST III trial presented during a Late-Breaking Clinical Trials session...</description>
                    <pubdate>1774791180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Emerging Trends in Multimodality Cardiovascular Imaging at AHA25</title>
<link>/Latest-in-Cardiology/Articles/2026/03/09/15/44/Emerging-Trends-in-Multimodality-Cardiovascular-Imaging-at-AHA25</link>                    <description>The American Heart Association (AHA) Scientific Sessions 2025 (AHA25) highlighted how quickly cardiovascular (CV) imaging is shifting toward integrated, biology-centered care.</description>
                    <pubdate>1773077700000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>COACT 5 Year Data: Similar Survival With Immediate vs. Delayed Coronary Angiography in OHCA Survivors</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/02/11/18/58/COACT-5</link>                    <description>At five years, survival was comparable between immediate and delayed angiography with no clinical benefit or harm in patients without ST-segment elevation resuscitated from out-of-hospital cardiac arrest (OHCA), according to new results from the randomized COACT trial published Feb. 4 in JACC.</description>
                    <pubdate>1770840780000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>